Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
暂无分享,去创建一个
O. Lavrik | J. Reynisson | J. Patel | N. Salakhutdinov | A. Zakharenko | E. Ilina | I. Leung | Ivanhoe K. H. Leung | D. Korchagina | T. Khomenko | K. Volcho | O. Zakharova | N. Popova | V. Nikolin | V. Kaledin | D. M. Ayine-Tora | A. Chepanova | R. Chand | Jinal N. Patel
[1] I. Qureshi,et al. Synthesis and biological evaluation of morpholines linked coumarin–triazole hybrids as anticancer agents , 2019, Chemical biology & drug design.
[2] C. Bailly. Irinotecan: 25 years of cancer treatment. , 2019, Pharmacological research.
[3] O. Lavrik,et al. New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors , 2019, Molecules.
[4] O. Lavrik,et al. Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells. , 2019, Journal of Natural Products.
[5] Zhi Xu,et al. Coumarin-containing hybrids and their anticancer activities. , 2019, European journal of medicinal chemistry.
[6] W. Reinhold,et al. Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents , 2019, bioRxiv.
[7] O. Lavrik,et al. The Development of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Combination of Monoterpene and Adamantine Moieties via Amide or Thioamide Bridges , 2019, Applied Sciences.
[8] O. Lavrik,et al. Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity , 2019, Medicinal research reviews.
[9] J. Singh,et al. Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. , 2019, Bioorganic & medicinal chemistry.
[10] Y. Pommier,et al. Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening. , 2019, Nucleic acids research.
[11] T. Bucciarelli,et al. UHPLC-UV/Vis Quantitative Analysis of Hydroxylated and O-prenylated Coumarins in Pomegranate Seed Extracts , 2019, Molecules.
[12] O. Lavrik,et al. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma , 2019, Bulletin of Experimental Biology and Medicine.
[13] B. Patel,et al. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update. , 2019, European journal of medicinal chemistry.
[14] O. Lavrik,et al. Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments. , 2019, Anti-cancer agents in medicinal chemistry.
[15] Seegehalli M. Anil,et al. Synthesis of new coumarin tethered isoxazolines as potential anticancer agents. , 2018, Bioorganic & medicinal chemistry letters.
[16] Zhi Xu,et al. Design, Synthesis, and Evaluation of Tetraethylene Glycol Tethered Isatin-Coumarin Hybrids as Novel Anticancer Agents , 2018, Journal of Heterocyclic Chemistry.
[17] S. B. Jonnalagadda,et al. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells. , 2018, Bioorganic & medicinal chemistry.
[18] J. Reynisson,et al. The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening , 2018, Molecular informatics.
[19] O. Lavrik,et al. A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold , 2018, Molecules.
[20] Yunxiang Liang,et al. A polysaccharide from Antrodia cinnamomea mycelia exerts antitumor activity through blocking of TOP1/TDP1-mediated DNA repair pathway. , 2018, International journal of biological macromolecules.
[21] Jong-Wha Jung,et al. Recent Advances in Synthesis of 4-Arylcoumarins , 2018, Molecules.
[22] S. Awale,et al. Chemical Constituents of Thai Citrus hystrix and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line. , 2018, Journal of natural products.
[23] B. Chelobanov,et al. Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors. , 2018, Bioorganic & medicinal chemistry.
[24] K. Majidzadeh-A,et al. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. , 2018, European journal of medicinal chemistry.
[25] Aliya Ibrar,et al. Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. , 2018, Bioorganic & medicinal chemistry.
[26] M. Mounier,et al. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells. , 2018, Bioorganic & medicinal chemistry.
[27] I. I. Popadyuk,et al. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors , 2018, Molecules.
[28] O. Lavrik,et al. Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors. , 2018, Bioorganic chemistry.
[29] F. Leonetti,et al. Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds , 2018, Molecules.
[30] O. Lavrik,et al. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy , 2018, Journal of enzyme inhibition and medicinal chemistry.
[31] L. Povirk,et al. Tyrosyl–DNA phosphodiesterases: rescuing the genome from the risks of relaxation , 2017, Nucleic acids research.
[32] S. Yachida,et al. Current status of poly(ADP-ribose) polymerase inhibitors and future directions , 2017, OncoTargets and therapy.
[33] S. D. Guggilapu,et al. Umbelliferone–oxindole hybrids as novel apoptosis inducing agents , 2017 .
[34] T. Pfeifer,et al. Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian fungus of the family Cortinariaceae. , 2017, Bioorganic & medicinal chemistry letters.
[35] V. Zarubaev,et al. Anti-influenza activity of monoterpene-containing substituted coumarins. , 2017, Bioorganic & medicinal chemistry letters.
[36] T. Yoshimura,et al. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity. , 2017, Bioorganic & medicinal chemistry letters.
[37] M. Itoigawa,et al. Cancer chemopreventive constituents from Melicope lunu-ankenda , 2017 .
[38] Petra Schneider,et al. Privileged Structures Revisited , 2017, Angewandte Chemie.
[39] F. Belluti,et al. Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity. , 2017, European journal of medicinal chemistry.
[40] V. Svedas,et al. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin. , 2016, Journal of natural products.
[41] O. Lavrik,et al. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties. , 2016, Bioorganic & medicinal chemistry.
[42] O. Lavrik,et al. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential. , 2016, Bioorganic & medicinal chemistry.
[43] N. Jain,et al. Synthesis and antiproliferative activity of 6,7-aryl/hetaryl coumarins , 2016, Russian Journal of General Chemistry.
[44] Haitao Liu,et al. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7‐Disubstituted Coumarin Derivatives as Potent Anticancer Agents , 2015, Chemical biology & drug design.
[45] M. D. Hill,et al. Applications of Fluorine in Medicinal Chemistry. , 2015, Journal of medicinal chemistry.
[46] R. Schmid,et al. The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl‐DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis , 2015, Arthritis & rheumatology.
[47] O. Lavrik,et al. Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety. , 2015, Bioorganic & medicinal chemistry.
[48] Steven J. M. Jones,et al. Identification of a Putative Tdp1 Inhibitor (CD00509) by in Vitro and Cell-Based Assays , 2014, Journal of biomolecular screening.
[49] S. Ward,et al. TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan , 2014, Journal of cancer science & therapy.
[50] M. O'sullivan,et al. TDP1 and PARP1 Deficiency Are Cytotoxic to Rhabdomyosarcoma Cells , 2013, Molecular Cancer Research.
[51] Feng Zhu,et al. Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study , 2012, Molecular informatics.
[52] J. Hashimoto,et al. Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus. , 2012, Journal of natural products.
[53] Y. Pommier,et al. Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells* , 2012, The Journal of Biological Chemistry.
[54] Y. Pommier,et al. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors , 2011, Expert opinion on therapeutic patents.
[55] S. Genovese,et al. Auraptene: a natural biologically active compound with multiple targets. , 2011, Current drug targets.
[56] C. Shayo,et al. Coumarins: old compounds with novel promising therapeutic perspectives. , 2010, Current medicinal chemistry.
[57] Iwona E. Weidlich,et al. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. , 2009, Journal of medicinal chemistry.
[58] Thomas Stützle,et al. Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..
[59] Jóhannes Reynisson,et al. Benchmarking the reliability of QikProp. Correlation between experimental and predicted values , 2008 .
[60] K. Caldecott,et al. TDP1 facilitates chromosomal single‐strand break repair in neurons and is neuroprotective in vivo , 2007, The EMBO journal.
[61] M. Bjornsti,et al. Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison. , 2007, Journal of molecular biology.
[62] Yves Pommier,et al. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1 , 2007, Nucleic acids research.
[63] M. Brock,et al. Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer. , 2007, Lung cancer.
[64] P. Houghton,et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] Yves Pommier,et al. Inhibition of Human Tyrosyl-DNA Phosphodiesterase by Aminoglycoside Antibiotics and Ribosome Inhibitors , 2006, Molecular Pharmacology.
[66] Marcel L Verdonk,et al. General and targeted statistical potentials for protein–ligand interactions , 2005, Proteins.
[67] J. Champoux,et al. SCAN1 mutant Tdp1 accumulates the enzyme–DNA intermediate and causes camptothecin hypersensitivity , 2005, The EMBO journal.
[68] Morten O. Christensen,et al. TDP1 Overexpression in Human Cells Counteracts DNA Damage Mediated by Topoisomerases I and II* , 2004, Journal of Biological Chemistry.
[69] Haruki Nakamura,et al. Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.
[70] Richard D. Taylor,et al. Improved protein–ligand docking using GOLD , 2003, Proteins.
[71] J. Champoux,et al. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. , 2002, Journal of molecular biology.
[72] Huili Chen,et al. Effects of phosphatidylinositol 4,5-bisphosphate and neomycin on phospholipase D: Kinetic studies , 1999, Molecular and Cellular Biochemistry.
[73] G. V. Paolini,et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..
[74] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[75] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[76] Isabel Leung,et al. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. , 2019, European journal of medicinal chemistry.
[77] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..